Medicus Pharma Ltd. Common Stock (MDCX) Stock Price
MDCXStock
$0.26−87.11%52W
Market Cap$16.28M
P/E—
PEG Ratio—
Div yield—
Beta-1.54
MDCX Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-89.90%
Price vs S&P 500 (4W)-15.93%
VGM Score22.11
MDCX Earnings Surprise History
| Quarter | Report date | EPS estimate | EPS actual | Surprise |
|---|---|---|---|---|
| Q2 2026 | -$0.16 | -$0.21 | -31.25%(-$0.05) | |
| Q1 2026 | -$0.22 | -$0.30 | -37.18%(-$0.08) | |
| Q4 2025 | -$0.29 | -$0.44 | -53.17%(-$0.15) | |
| Q3 2025 | -$0.38 | -$1.09 | -187.71%(-$0.71) | |
| Q2 2025 | -$0.27 | -$0.42 | -57.89%(-$0.15) |
MDCX Analyst Recommendations
May 2026
Jun 2026
Jul 2026
Aug 2026
4.10
4.11
4.11
4.10
Industry Peers — Pharmaceuticals(570)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
MDCXMedicus Pharma Ltd. Common Stock | — | — | D | $0.26 |
| LLYEli Lilly & Co. | D | B | C | $1174.61 |
| JNJJohnson & Johnson | D | C | B | $268.04 |
| ABBVABBVIE INC. | D | C | B | $255.48 |
| MRKMerck & Co., Inc. | D | C | B | $148.35 |
| NVSNovartis AG | C | C | C | $153.81 |
| AZNAstraZeneca PLC | C | B | C | $162.70 |
| NVONovo-Nordisk A/S | B | C | C | $45.61 |
| ABTAbbott Laboratories | C | C | C | $112.47 |
| PFEPfizer Inc. | C | D | B | $27.96 |
| VRTXVertex Pharmaceuticals Inc | D | C | B | $541.69 |
About Medicus Pharma Ltd. Common Stock
Medicus Pharma Ltd is a clinical-stage holding company that invests in and supports life sciences and biotechnology companies developing novel treatments. The company focuses on advancing therapies through FDA-regulated clinical development to address unmet patient needs and improve therapeutic outcomes.